← FDA DRUG APPROVALS

FDA ANDA · ANDA065151

CYCLOSPORINE

Sponsor: PADAGIS US

APPLICATION
ANDA065151
TYPE
ANDA
ORIGINAL APPROVAL
2003-10-07
LATEST ACTION
2015-06-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CYCLOSPORINEDiscontinued
CYCLOSPORINE 50MG/ML · INJECTABLE · INJECTION

Approval history

2015-06-30Labeling · Supplement 13 · standardAP
2015-06-30Labeling · Supplement 10AP
2012-01-31Labeling · Supplement 9AP
2006-10-10Labeling · Supplement 4AP
2005-06-24Labeling · Supplement 3AP
2003-10-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →